Ting Wang

发表

Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)Validation.

S. Viatchenko‐Karpinski, J. Sudhamsu, Xiaowu Chen, 2019, ACS medicinal chemistry letters.

Synthesis and optical properties of novel D–π–A–π–D type cationic cyclopentadienyliron complexes of arenes

Ting Wang, Baodong Zhao, Yawei Shi, 2015 .

Metabolism and Pharmacokinetics of the Anti-Hepatitis C Virus Nucleotide Prodrug GS-6620

D. Stefanidis, A. Ray, Yeojin Park, 2014, Antimicrobial Agents and Chemotherapy.

Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus

A. Mathias, N. Afdhal, J. McHutchison, 2018, Antimicrobial Agents and Chemotherapy.

Direct Measurement of the Intracellular Concentration of 8-Oxo-2'-Deoxyguanosine-5'-Triphosphate by LC-MS/MS

K. Schwartz, A. Ray, Ting Wang, 2020 .

Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines.

I. Pichová, R. Pohl, Michal Hocek, 2011, Journal of medicinal chemistry.

Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients.

W. Zhong, M. Fenaux, H. Ye, 2014, Journal of medicinal chemistry.

Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable properties.

Huiling Yang, T. Appleby, M. Fenaux, 2017, Bioorganic & medicinal chemistry letters.

Synthesis and characterization of 2'-C-Me branched C-nucleosides as HCV polymerase inhibitors.

A. Ray, Joy Y. Feng, D. Babusis, 2012, Bioorganic & medicinal chemistry letters.

6-(Het)aryl-7-deazapurine ribonucleosides as novel potent cytostatic agents.

R. Pohl, Michal Hocek, R. Mackman, 2010, Journal of medicinal chemistry.

Nucleotide Prodrug Containing a Nonproteinogenic Amino Acid To Improve Oral Delivery of a Hepatitis C Virus Treatment

Huiling Yang, M. Fenaux, Neeraj Tirunagari, 2018, Antimicrobial Agents and Chemotherapy.

Implications of Efficient Hepatic Delivery by Tenofovir Alafenamide (GS-7340) for Hepatitis B Virus Therapy

A. Ray, Yeojin Park, D. Babusis, 2015, Antimicrobial Agents and Chemotherapy.

Species differences in liver accumulation and metabolism of nucleotide prodrug sofosbuvir.

A. Ray, Yeojin Park, D. Babusis, 2020, Drug Metabolism and Pharmacokinetics.

1 Non-proteinogenic Amino Acid Containing Nucleotide Prodrug to Improve Oral Delivery of a 1 Hepatitis C Virus Treatment 2

Huiling Yang, M. Fenaux, Neeraj Tirunagari, 2018 .

Biochemical characterization of tirabrutinib and other irreversible inhibitors of Bruton's tyrosine kinase reveals differences in on - and off - target inhibition.

Gregg A. Czerwieniec, A. Ray, Joy Y. Feng, 2020, Biochimica et biophysica acta. General subjects.

Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.

P. Muti, J. Greenwood, Y. Hoshida, 2019, Cell metabolism.

Biochemical Characterization of GS-4059 As a Potent and Selective Covalent Irreversible Inhibitor of Bruton's Tyrosine Kinase

A. Ray, Joy Y. Feng, R. Sakowicz, 2016 .